Content validation of a pre-treatment oral oncolytic non-adherence estimator (ORACLE)
Journal of Oncology Pharmacy Practice
Published online on March 31, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundOral anti-cancer treatment is commonly used, and non-adherence can negatively affect outcomes. The Oral Oncolytic Non-Adherence Estimator (ORACLE) was designed to prospectively categorize patients into risk levels by considering constructs such ...
BackgroundOral anti-cancer treatment is commonly used, and non-adherence can negatively affect outcomes. The Oral Oncolytic Non-Adherence Estimator (ORACLE) was designed to prospectively categorize patients into risk levels by considering constructs such ...